🔗 Share this article

A shadow economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Investigational Drug Acquiring Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to message these profiles directly for source information, while also obtaining discount codes.

Thriving Commerce on Social Networks

Separately, a robust market exists on Telegram, where communities with thousands of members share comparison images, administration instructions and claims of rapid UK delivery. Sellers promote the substance there before directing customers to other platforms for purchases.

Learning About Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Experts Voice Concerns

Nevertheless, physicians and pharmacists have cautions that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to users injecting substances of unknown origin.

Some professionals said the demand for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several influencers try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach medicines, advertising, and consumer laws, risking fines, legal action or imprisonment.

Service Response and Material Removal

According to the social media company, the service has taken down problematic material and prohibited related hashtags and search suggestions. The organization said it was committed to keeping the platform safe and investing in strengthening enforcement strategies.

Online Trading Activities

Investigations also found communities with up to 9,000 members marketing retatrutide using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, populated with photos of weight loss, glowing reviews and detailed guides for preparing or administering at residence.

After minutes of joining one group, a vendor shared WhatsApp details, where most transactions take place. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about body mass, health issues or past usage.

Product Information and Costs

Within these groups, messages display black plastic packages with Royal Mail stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors usually priced at £160 for 20mg. When questioned how long a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for Telegram stated it actively monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering substances they can’t verify. Although the research behind retatrutide is sound, these digital products may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in demand to current price rises for approved slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she explained.

Her staff has already seen individuals harmed by personal administration from unconfirmed sources. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your health,” said the doctor. “These materials could be impure or improperly measured.”

Producer Statement

A representative from Eli Lilly said the substance was in third stage research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose users to possibly serious health risks”.